Carotid body tumor epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 2: | Line 2: | ||
{{Carotid body tumor}} | {{Carotid body tumor}} | ||
{{CMG}}; {{AE}} {{Sahar}} | {{CMG}}; {{AE}} {{Sahar}} {{MV}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of [[carotid body]] [[tumor]] is less than 3 in 100,000 individuals. It is the most common | The [[incidence]] of [[carotid body]] [[tumor]] is less than 3 in 100,000 individuals. It is the most common [[paraganglioma]] of the head and [[neck]] and comprises approximately 65% of [[paragangliomas]]. The [[prevalence]] of head and [[neck]] [[paraganglioma]] is 3% of all [[paraganglioma]]. This [[tumor]] is more commonly observed in the adults and particularly in their fifth decade of life. It affects both gender equally. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
| Line 11: | Line 11: | ||
===Prevalence=== | ===Prevalence=== | ||
* The [[prevalence]] of [[carotid body]] [[tumor]] is approximately 65% of head and neck [[paraganglioma]].<ref name="XiaoShe2015">{{cite journal|last1=Xiao|first1=Zebin|last2=She|first2=Dejun|last3=Cao|first3=Dairong|title=Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report|journal=BMC Medical Imaging|volume=15|issue=1|year=2015|issn=1471-2342|doi=10.1186/s12880-015-0082-z}}</ref> | * The [[prevalence]] of [[carotid body]] [[tumor]] is approximately 65% of head and neck [[paraganglioma]].<ref name="XiaoShe2015">{{cite journal|last1=Xiao|first1=Zebin|last2=She|first2=Dejun|last3=Cao|first3=Dairong|title=Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report|journal=BMC Medical Imaging|volume=15|issue=1|year=2015|issn=1471-2342|doi=10.1186/s12880-015-0082-z}}</ref> | ||
* The [[prevalence]] of head and neck paraganglioma is 3% of all paraganglioma. | * The [[prevalence]] of head and neck [[paraganglioma]] is 3% of all [[paraganglioma]]. | ||
* The estimated [[prevalence]] of [[parasymapathetic]] paraganglioma is approximately 1-2 cases per 100,000 individuals worldwide. | * The estimated [[prevalence]] of [[parasymapathetic]] [[paraganglioma]] is approximately 1-2 cases per 100,000 individuals worldwide. | ||
===Age=== | ===Age=== | ||
*[[Carotid body]] [[tumor]] is more commonly observed in the adults and particularly in their fifth decade of life.<ref name="LeeOh2006">{{cite journal|last1=Lee|first1=Ki Yeol|last2=Oh|first2=Yu-Whan|last3=Noh|first3=Hyung Jun|last4=Lee|first4=Yu Jin|last5=Yong|first5=Hwan-Seok|last6=Kang|first6=Eun-Young|last7=Kim|first7=Kyeong Ah|last8=Lee|first8=Nam Joon|title=Extraadrenal Paragangliomas of the Body: Imaging Features|journal=American Journal of Roentgenology|volume=187|issue=2|year=2006|pages=492–504|issn=0361-803X|doi=10.2214/AJR.05.0370}}</ref> | *[[Carotid body]] [[tumor]] is more commonly observed in the adults and particularly in their fifth decade of life.<ref name="LeeOh2006">{{cite journal|last1=Lee|first1=Ki Yeol|last2=Oh|first2=Yu-Whan|last3=Noh|first3=Hyung Jun|last4=Lee|first4=Yu Jin|last5=Yong|first5=Hwan-Seok|last6=Kang|first6=Eun-Young|last7=Kim|first7=Kyeong Ah|last8=Lee|first8=Nam Joon|title=Extraadrenal Paragangliomas of the Body: Imaging Features|journal=American Journal of Roentgenology|volume=187|issue=2|year=2006|pages=492–504|issn=0361-803X|doi=10.2214/AJR.05.0370}}</ref> | ||
| Line 27: | Line 27: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: | [[Category:Up-To-Date]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 20:49, 29 July 2020
|
Carotid body tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carotid body tumor epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Carotid body tumor epidemiology and demographics |
|
Carotid body tumor epidemiology and demographics in the news |
|
Risk calculators and risk factors for Carotid body tumor epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2] Maria Fernanda Villarreal, M.D. [3]
Overview
The incidence of carotid body tumor is less than 3 in 100,000 individuals. It is the most common paraganglioma of the head and neck and comprises approximately 65% of paragangliomas. The prevalence of head and neck paraganglioma is 3% of all paraganglioma. This tumor is more commonly observed in the adults and particularly in their fifth decade of life. It affects both gender equally.
Epidemiology and Demographics
Incidence
- The incidence of this tumor is less than 3 in 100,000 individuals.[1]
- The incidence of malignant case has been observed to be 10%.[2]
Prevalence
- The prevalence of carotid body tumor is approximately 65% of head and neck paraganglioma.[3]
- The prevalence of head and neck paraganglioma is 3% of all paraganglioma.
- The estimated prevalence of parasymapathetic paraganglioma is approximately 1-2 cases per 100,000 individuals worldwide.
Age
- Carotid body tumor is more commonly observed in the adults and particularly in their fifth decade of life.[4]
- In familial cases, the mean age of onset is younger, being the second or fourth decade of life.[5]
Gender
- There is no gender preference in the incidence of this tumor according to the recent literature except in the high altitude where the tumor is more prevalent among women.[5][6]
Race
- There is no racial predilection to carotid body tumor.
References
- ↑ Wieneke, Jacqueline A.; Smith, Alice (2009). "Paraganglioma: Carotid Body Tumor". Head and Neck Pathology. 3 (4): 303–306. doi:10.1007/s12105-009-0130-5. ISSN 1936-055X.
- ↑ Bakoyiannis KC, Georgopoulos SE, Klonaris CN, Tsekouras NS, Felekouras ES, Pikoulis EA, Griniatsos JE, Papalambros EL, Bastounis EA (March 2006). "Surgical treatment of carotid body tumors without embolization". Int Angiol. 25 (1): 40–5. PMID 16520723.
- ↑ Xiao, Zebin; She, Dejun; Cao, Dairong (2015). "Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report". BMC Medical Imaging. 15 (1). doi:10.1186/s12880-015-0082-z. ISSN 1471-2342.
- ↑ Lee, Ki Yeol; Oh, Yu-Whan; Noh, Hyung Jun; Lee, Yu Jin; Yong, Hwan-Seok; Kang, Eun-Young; Kim, Kyeong Ah; Lee, Nam Joon (2006). "Extraadrenal Paragangliomas of the Body: Imaging Features". American Journal of Roentgenology. 187 (2): 492–504. doi:10.2214/AJR.05.0370. ISSN 0361-803X.
- ↑ 5.0 5.1 Burgess, Alfred; Calderon, Moises; Jafif-Cojab, Marcos; Jorge, Diego; Balanza, Ricardo (2017). "Bilateral carotid body tumor resection in a female patient". International Journal of Surgery Case Reports. 41: 387–391. doi:10.1016/j.ijscr.2017.11.019. ISSN 2210-2612.
- ↑ Jin ZQ, He W, Wu DF, Lin MY, Jiang HT (September 2016). "Color Doppler Ultrasound in Diagnosis and Assessment of Carotid Body Tumors: Comparison with Computed Tomography Angiography". Ultrasound Med Biol. 42 (9): 2106–13. doi:10.1016/j.ultrasmedbio.2016.04.007. PMID 27316787.